1.
May Engeseth G, Bolstad Hysing L, Yepes P, Seime Pettersen HE, Mohan R, Dave Fuller C, et al. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer. AO [Internet]. 2022 Feb. 1 [cited 2026 May 2];61(2):215-22. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/21377